Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$13.78 - $18.8 $219,611 - $299,615
15,937 New
15,937 $299,000
Q3 2023

Nov 02, 2023

BUY
$16.59 - $23.77 $887,913 - $1.27 Million
53,521 Added 57.39%
146,779 $2.55 Million
Q2 2023

Jul 31, 2023

BUY
$19.27 - $24.63 $1.8 Million - $2.3 Million
93,258 New
93,258 $1.94 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.